Matthew Hotopf
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Matthew Hotopf is a British psychiatrist.
Hotopf developed an interest in chronic fatigue syndrome when, as a medical student, he suffered from glandular fever and enrolled into Peter White's study on peristent fatigue following an Epstein-Barr virus infection.[1]
Notable studies
- 2005, A systematic review describing the prognosis of chronic fatigue syndrome[2] (Full text)
- 2005, The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis[3] (Full text)
- 2019, Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome[4] (Full text)
Books
- 1999, Chronic Fatigue and its Syndromes, with Simon Wessely and Michael Sharpe
See also
Learn more
References
- ↑ Chronic Fatigue and its Syndromes. Oxford University Press. 1999.
- ↑ Cairns, Ruth; Hotopf, Matthew (January 2005). "A systematic review describing the prognosis of chronic fatigue syndrome". Occupational Medicine (Oxford, England). 55 (1): 20–31. doi:10.1093/occmed/kqi013. ISSN 0962-7480. PMID 15699087.
- ↑ Cho, Hyong Jin; Hotopf, Matthew; Wessely, Simon (March 2005). "The placebo response in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis". Psychosomatic Medicine. 67 (2): 301–313. doi:10.1097/01.psy.0000156969.76986.e0. ISSN 1534-7796. PMID 15784798.
- ↑ Russell, Alice; Hepgul, Nilay; Nikkheslat, Naghmeh; Borsini, Alessandra; Zajkowska, Zuzanna; Moll, Natalie; Forton, Daniel; Agarwal, Kosh; Chalder, Trudie; Mondelli, Valeria; Hotopf, Matthew; Cleare, Anthony; Murphy, Gabrielle; Wong, Terry; Foster, Graham; Schütze, Gregor A.; Schwarz, Markus J.; Harrison, Neil; Zunszain, Patricia; Pariante, Carmine (2018). "Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome". Psychoneuroendocrinology. doi:10.1016/j.psyneuen.2018.11.032. ISSN 0306-4530. Retrieved December 18, 2018.
